Compounds > ramosetron
Page last updated: 2024-09-02

ramosetron and domperidone

ramosetron has been researched along with domperidone in 1 studies

Compound Research Comparison

Studies
(ramosetron)		Trials
(ramosetron)		Recent Studies (post-2010)
(ramosetron)		Studies
(domperidone)		Trials
(domperidone)		Recent Studies (post-2010) (domperidone)
19494831,977275468

Protein Interaction Comparison

ProteinTaxonomyramosetron (IC50)domperidone (IC50)
Solute carrier family 22 member 2Homo sapiens (human)7.9
5-hydroxytryptamine receptor 4Cavia porcellus (domestic guinea pig)1.332
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)2.614
Alpha-2A adrenergic receptorHomo sapiens (human)2.74
D(2) dopamine receptorHomo sapiens (human)0.0026
Alpha-2B adrenergic receptorHomo sapiens (human)2.125
Alpha-2C adrenergic receptorHomo sapiens (human)1.011
Sodium-dependent noradrenaline transporter Homo sapiens (human)2.614
Alpha-1D adrenergic receptorHomo sapiens (human)1.065
5-hydroxytryptamine receptor 2AHomo sapiens (human)0.037
5-hydroxytryptamine receptor 2CHomo sapiens (human)1.332
Sodium-dependent serotonin transporterHomo sapiens (human)3.055
Histamine H1 receptorHomo sapiens (human)1.344
Mu-type opioid receptorHomo sapiens (human)4.218
D(3) dopamine receptorHomo sapiens (human)0.018
Kappa-type opioid receptorHomo sapiens (human)6.994
5-hydroxytryptamine receptor 2BHomo sapiens (human)2.6
D(2) dopamine receptorRattus norvegicus (Norway rat)0.0052
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)0.1447
Multidrug and toxin extrusion protein 1Homo sapiens (human)2.3

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ando, T; Ikeoka, T; Imaizumi, M; Kawakami, A; Ueki, I; Usa, T1

Other Studies

1 other study(ies) available for ramosetron and domperidone

ArticleYear
Moderate to severe nausea in radioactive iodine (RAI) therapy is associated with the RAI dose per body weight and was not prevented by ramosetron.
    Endocrine, 2014, Volume: 46, Issue:1

    Topics: Adenoma; Adult; Aged; Antiemetics; Benzimidazoles; Domperidone; Dose-Response Relationship, Radiation; Female; Fluid Therapy; Humans; Iodine Radioisotopes; Male; Middle Aged; Nausea; Risk Factors; Thyroid Neoplasms; Vomiting

2014